Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-08-26 | Dr. Small-Howard authored and/or attained 12 patents & 3 trademarks on proprietary cancer tests, cancer (gene) therapies, cosmeceuticals, and animal models. |
| 2017-08-08 | Dr. Andrea Small-Howard, PhD, MBA, Chief Science Officer and Director... She authored and/or attained 12 patents & 3 trademarks on proprietary cancer tests, cancer (gene) therapies, cosmeceuticals, and animal models. |
| 2018-01-12 | Dr. Andrea Small-Howard is listed as a director and beneficial owner, but there is no indication of software or technical background. |
| 2018-11-02 | Dr. Andrea Small-Howard ... No mention of software or technical background. |
| 2019-07-02 | Dr. Andrea Small-Howard ... No mention of software-related technical skills or programming experience. |
| 2023-01-19 | Dr. Small-Howard’s goal has been to create and maintain a novel plant-inspired therapy pipeline based on the Company's proprietary in silico technology suite, direct research & development efforts, facilitate research and development partnerships, guide product commercialization strategies, develop corporate messaging around our novel drug discovery process, and make public presentations promoting the Company’s drug development programs and unique corporate strategy. |
Data sourced from SEC filings. Last updated: 2026-02-03